ENHANCED GENERATION OF OK-432-INDUCED KILLER-CELLS BY INTERLEUKIN-2

被引：0
|
作者：
UJIIE, T
机构：
来源：
JAPANESE JOURNAL OF EXPERIMENTAL MEDICINE | 1987年 / 57卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：183 / 188
页数：6
相关论文
共 50 条
  • [11] KILLER-CELLS INDUCED BY STIMULATION WITH ALLOGENEIC-TUMOR CELLS AND SUBSEQUENT CULTURE WITH RECOMBINANT INTERLEUKIN-2
    FUKIAGE, T
    MURAKAMI, H
    EURA, M
    IKAWA, T
    ISHIKAWA, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 33 (03) : 139 - 145
  • [12] AUGMENTATION OF INTERLEUKIN-1 AND INTERLEUKIN-2 PRODUCTION BY OK-432
    ICHIMURA, O
    SUZUKI, S
    SAITO, M
    SUGAWARA, Y
    ISHIDA, N
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (02): : 263 - 270
  • [13] TREATMENT OF CANCER WITH LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 - REPLY
    ROSENBERG, SA
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (15): : 962 - 963
  • [14] THE NEUROPSYCHIATRIC EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    DENICOFF, KD
    RUBINOW, DR
    PAPA, MZ
    SIMPSON, C
    SEIPP, CA
    LOTZE, MT
    CHANG, AE
    ROSENSTEIN, D
    ROSENBERG, SA
    ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) : 293 - 300
  • [15] EFFECTS OF RECOMBINANT INTERFERON-GAMMA AND INTERLEUKIN-2 ON THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS INVITRO
    FINDLEY, HW
    NASR, S
    AFIFY, Z
    HNATH, R
    WALDREP, K
    RAGAB, AH
    CANCER INVESTIGATION, 1990, 8 (05) : 493 - 500
  • [16] LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTORS ARE PREDICTIVE OF RESPONSE IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    PAIETTA, E
    NELSON, DL
    ANDERSEN, J
    DUTCHER, JP
    WIERNIK, PH
    MEDICAL ONCOLOGY, 1995, 12 (02): : 121 - 124
  • [17] INTERLEUKIN-2 KILLER-CELLS - IN-VITRO EVALUATION OF COMBINATION WITH PROTHYMOSIN-ALPHA
    LOPEZRODRIGUEZ, JL
    CORDERO, OJ
    SARANDESES, C
    VINUELA, J
    NOGUEIRA, M
    LYMPHOKINE AND CYTOKINE RESEARCH, 1994, 13 (03): : 175 - 182
  • [18] THYROID FUNCTIONS IN PATIENTS TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    KUNG, AWC
    LAI, CL
    WONG, KL
    TAM, CF
    QUARTERLY JOURNAL OF MEDICINE, 1992, 82 (297): : 33 - 42
  • [19] HEMODYNAMIC-EFFECTS OF REDUCED DOSE INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER-CELLS
    FROMM, RE
    OGNIBENE, FP
    PARKER, MM
    BOOKMAN, M
    PARRILLO, JE
    CLINICAL RESEARCH, 1987, 35 (05): : A787 - A787
  • [20] THE ADOPTIVE IMMUNOTHERAPY OF CANCER USING LYMPHOKINE ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2
    ETTINGHAUSEN, SE
    ROSENBERG, SA
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1986, 9 (01): : 51 - 71
12345